Completely agree @Dhm
The lack of telehealth signups in Europe/UK is my biggest concern. Michael Stein and Jamie Joint have been on the ground almost two years and the only telehealth deal is that's been executed is Medgate. Two years!
IMO the next two weeks and the quarterly report are critical for the current BOD and Management. We should have news on SleepCheck FDA, DX FDA meeting, Covid test results, revenue and potential new deals. If the results are not satisfactory I believe we as shareholders need to consider calling an EGM or at the very least we need to be convinced why we shouldn't sell our shares and invest them somewhere else.
I hope they can produce some results, I really do. EGM's and board spills are not pleasant but everyone is accountable, especially at board level. IMO if the results are not satisfactory and the current board want to remain they need to commit to a date when they will achieve 6 Million in revenue per annum (breakeven). Then we're all clear on the objective and its definitive and measurable.
Let's hope we have some very positive announcements over the next two weeks. I speak with management regularly and I understand there are good things happening but results are all that count now. We need to see results.
Completely agree @DhmThe lack of telehealth signups in Europe/UK...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #